CompletedNot applicableNCT04399954
Evaluation of Ketoflo
Studying Classic glucose transporter type 1 deficiency syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vitaflo International, Ltd
- Principal Investigator
- Kathryn LightfootLeeds Teaching Hospitals NHS Trust
- Intervention
- Ketoflo(dietary_supplement)
- Enrollment
- 25 enrolled
- Eligibility
- 3-18 years · All sexes
- Timeline
- 2020 – 2023
Study locations (5)
- Royal Aberdeen Children's Hospital, Aberdeen, United Kingdom
- Barberry, Birmingham, United Kingdom
- Bristol Royal Hospital for Children, Bristol, United Kingdom
- Leeds Children's Hospital, Leeds, United Kingdom
- Great Ormond Street Hospital for Children, London, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04399954 on ClinicalTrials.govOther trials for Classic glucose transporter type 1 deficiency syndrome
Additional recruiting or active studies for the same condition.
See all trials for Classic glucose transporter type 1 deficiency syndrome →